搜尋結果
再鼎醫藥:奧凱樂獲內地批准用於治療ROS1陽性非小細胞肺癌
infocast via Yahoo財經香港· 1 日前再鼎醫藥(09688)宣布,奧凱樂®(瑞普替尼)已獲中國國家藥品監督管理局批准,用於治療ROS1陽性的局部晚期或轉移性非小細胞肺癌成人患者。奧凱樂(瑞普替尼 ...
Billionaire-Backed Cancer Researcher Claire Mazumdar Finds Entrepreneurial Niche
Forbes· 4 日前Mazumdar, 35, is the CEO of Boston-based Bicara Therapeutics, a Biocon spinoff that’s ...
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
CNBC· 6 日前The injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on ...
FDA To Hold Advisory Committee Meeting On MDMA Therapy For PTSD, Welcomes Public Comment
Forbes· 3 日前The U.S. Food and Drug Administration (FDA) recently announced an upcoming committee meeting ...
落戶香港|45家生科公司落戶香港 投資推廣署:香港有成國際生命健康中心條件 - 香港經濟日報 - 即時新 ...
經濟日報· 5 日前投資推廣署署長劉凱旋表示,投資推廣署與引進重點企業辦公室合作,自2022年12月起,在不足兩年間吸引了來自9個國家及地區、45家重點生物科技公司落戶香港, ...
Is Eli Lilly Stock A Better Pick Over Amgen?
Forbes· 21 小時前Also, Eli Lilly has seen a better revenue growth and is more profitable. There is more to the ...
Barclays upgrades a little-known biotech stock that it says can more than double
CNBC· 3 日前This drug discovery stock can benefit from expansion of its breast cancer treatment.
Here are Friday's biggest analyst calls of the day: Nvidia, Tesla, Apple, 3M, Bumble, Nike, ...
CNBC· 4 日前Here are the biggest calls on Wall Street on Friday: Bernstein reiterates Nvidia as outperform ...
US FDA panel to discuss first psychedelic-assisted PTSD treatment next month (May 6)
Reuters· 5 日前The U.S. FDA's panel of independent advisers will on June 4 deliberate whether they should ...
Will Amgen Stock Continue To See Higher Levels Driven By Its Obesity Injection?
Forbes· 6 日前Firstly, let us look at Amgen’s stock performance. AMGN stock has shown gains of 30% from ...
therapeutics 相關
廣告